
InsiderCX raises €1.5M to boost patient experience
InsiderCX secured a €1.5M seed round led by GapMinder to scale its AI patient experience platform across Europe and expand product innovation.
TL;DR
Croatia-based InsiderCX has secured €1.5M in seed funding led by GapMinder, with Silicon Gardens Fund participating. The company will use the capital to expand across Europe and strengthen its AI that turns patient feedback—especially open-text comments—into actionable insights for providers and insurers, quicker complaint resolution, and more positive online reviews.
InsiderCX, an AI-driven patient experience platform headquartered in Varaždin, Croatia, has raised €1.5 million in a Seed funding round, signaling fresh momentum for healthcare providers and insurers that want to improve patient satisfaction with data-backed, operationally useful insights. In this update for the ai world organisation audience, the deal is also a practical example of how applied healthcare AI is moving from “nice-to-have analytics” to real workflow infrastructure—exactly the kind of market shift that deserves deeper discussion at the ai world summit and across ai world organisation events and ai conferences by ai world, including AI World Summit 2025 / 2026.
InsiderCX’s €1.5M seed round and why it matters now
The €1.5 million Seed round positions InsiderCX to accelerate its next growth phase at a time when patient expectations increasingly mirror consumer-grade experiences: fast responses, transparent communication, and visible follow-through. In the context of the ai world organisation, this funding story isn’t only about capital—it’s about how healthcare organisations are investing in the “experience layer” as a measurable lever for retention, reputation, and service quality, a recurring theme for the ai world summit and other ai world organisation events.
InsiderCX describes itself as an AI-powered feedback platform built for “closing the loop,” shifting healthcare teams from guessing what patients feel to measuring why patients return. That positioning matters because it implies an operational promise: feedback should not remain trapped in dashboards; it should translate into actions that clinics, hospitals, and insurers can execute quickly and consistently, a point that aligns well with the applied-AI focus often showcased through ai conferences by ai world and sessions at the ai world summit.
This round is also notable because it reinforces the broader European trend: specialised healthtech platforms are gaining traction by solving concrete, daily problems—complaints, response speed, review management, and service recovery—rather than only selling abstract “AI transformation.” For AI World Summit 2025 / 2026 programming, this is the kind of tangible case study that helps decision-makers connect AI narratives to outcomes: improved patient experience, faster remediation, and clearer accountability.
Investors behind the round: GapMinder and Silicon Gardens Fund
The Seed round was led by GapMinder, with participation from Silicon Gardens Fund and existing venture partners. GapMinder is positioned as a venture capital firm focused on high-growth B2B technology startups in Romania and Southeast Europe, and it typically leads Seed and Late Seed rounds.
GapMinder’s Fund II is described as an €80 million fund, and the firm’s initial investment tickets are typically in the €500,000 to €2.5 million range, which helps explain why a €1.5 million round fits naturally within its strategy. For founders and operators tracking ai world organisation events and ai conferences by ai world, this is also a reminder that “regional” funds in Southeast Europe are increasingly comfortable backing AI-centric platforms that aim to expand across multiple European markets.
Additional reporting notes that InsiderCX is based in Varaždin/Zagreb and frames the raise as fuel for market expansion and product growth, while identifying Nikola Komes as a key founder figure (and also referencing a CTO in that coverage). Separate coverage also highlights that the funding round includes existing investor Silicon Gardens Fund and ties the capital to expanding product capabilities and entering new markets.
From the ai world organisation perspective, there is a useful narrative thread here: AI innovation in healthcare isn’t only funded by the largest global firms; it is increasingly financed by specialised regional investors who understand the local market dynamics—regulation, provider fragmentation, language needs, and cross-border scaling. That reality fits well with the ai world summit mission of convening innovators and leaders from across geographies, and it’s also why ai world organisation events benefit when they include both founders and investors shaping real adoption pathways.
How InsiderCX plans to use the funding
InsiderCX plans to use the €1.5 million to accelerate growth across European markets, expand its AI capabilities, and support product development for healthcare providers and insurers. In practical terms, this kind of allocation usually means more than “building features”: it suggests faster onboarding, deeper language and workflow coverage, and stronger integration of patient feedback into operational processes that clinics and insurance partners can actually sustain.
On the product side, InsiderCX positions its platform around collecting patient-reported data that is measurable and scalable, reinforcing that its aim is to make experience improvement systematic rather than ad hoc. The platform overview emphasizes automated feedback collection and making insights visible in a way that helps teams respond faster and make more informed decisions, which aligns closely with the “close the loop” philosophy that many patient experience leaders seek but often struggle to operationalise.
The original funding brief also states that InsiderCX uses AI to identify experience gaps, address complaints, automate analysis of open-text feedback, and convert positive patient experiences into online reviews. This matters because it connects three typically separate workflows—patient feedback, quality improvement, and reputation management—into one loop, which can reduce the delay between what patients report and what leadership teams actually fix.
For the ai world organisation audience, the most relevant takeaway is not the amount alone—it’s the strategic direction of spend: expanding AI capability while building for two buyer groups (providers and insurers) indicates an ambition to become a shared system of record for experience signals across the care journey. This is the kind of platform-level ambition that becomes especially interesting for debate at the ai world summit and AI World Summit 2025 / 2026, where stakeholders can pressure-test questions like transparency, bias in language analysis, and what “good” patient experience measurement should look like across different health systems.
What InsiderCX does across the patient journey
InsiderCX was founded in 2022 by Nikola Komes, and it is presented as an AI-powered patient experience platform that enables healthcare providers and insurers to collect actionable feedback across the patient journey. The platform’s proposition is to help organisations move from raw feedback to decisions by using AI to find patterns and gaps, particularly in open-text responses where traditional survey tools often fall short.
InsiderCX’s own positioning frames the product as a patient experience and feedback platform designed to stop organisations from “guessing what’s working” and instead measure why patients return, using patient-reported data. In its platform materials, InsiderCX also highlights that automated feedback collection can help organisations better understand what patients like and where they need to provide more information, while supporting faster responses through shared, real-time access to insights.
A key element in the original funding description is the “closing the loop” approach: identifying experience gaps, addressing complaints, automating analysis of open-text feedback, and turning positive experiences into online reviews. That combination is important in healthcare, where many providers face a dual challenge—improving service quality internally while also maintaining public trust and reputation externally—and where reputation signals can influence patient choice in competitive private healthcare markets.
The funding brief also describes InsiderCX as operating in six markets and serving major hospitals, dental groups, insurers, and international healthcare chains. While the article’s core is business news, it reflects a bigger operational truth relevant to AI World Summit 2025 / 2026: once a platform works across multiple markets, the complexity shifts toward governance—standardising experience measurement while respecting local expectations, languages, and regulatory requirements.
From the ai world organisation standpoint, it’s also worth spotlighting that patient experience is one of the clearest “human-facing” applications of AI: the value is judged by whether people feel heard, whether resolution is timely, and whether care communication becomes clearer. That human outcome focus is exactly why healthcare AI stories resonate beyond technical audiences at the ai world summit and across ai world organisation events and ai conferences by ai world—because they connect AI to dignity, trust, and real-world service improvement.
Why this funding story fits the AI World Summit 2025 / 2026 agenda
The AI World Summit is described as a premier gathering of AI pioneers, educators, policymakers, and industry leaders, designed around insights, collaboration, and shaping an AI-driven future. That framing makes InsiderCX’s milestone particularly relevant, because healthcare is one of the highest-stakes environments for applied AI: the end goal is not simply optimisation, but improving experience quality in ways patients can feel and organisations can verify.
The ai world organisation’s broader events messaging focuses on bringing together leading minds in AI and business, networking with industry leaders, and gaining actionable insights to drive business forward—language that strongly matches what operators and investors want when examining Seed-stage healthcare AI platforms scaling across Europe. In other words, the InsiderCX round is not just “startup news”; it’s a conversation starter for panels and roundtables about patient-centric metrics, complaint resolution workflows, ethical text analytics, and how insurers and providers can align on experience standards.
For AI World Summit 2025 / 2026, this story can also be used as a practical lens on Europe’s healthtech opportunity: investors are backing platforms that translate feedback into action, and founders are designing products that can operate across multiple markets and buyer types. If you’re part of the ai world organisation community, it’s the kind of development to track closely—not only to celebrate funding, but to ask sharper questions about what “good” looks like when AI evaluates human experience at scale.
Finally, for readers following ai world organisation events and ai conferences by ai world, InsiderCX is a reminder that “AI in healthcare” isn’t limited to diagnostics and imaging; experience management is becoming a competitive differentiator, and AI is increasingly used to interpret patient voice data and reduce the time between insight and improvement. That wider definition of healthcare AI is precisely where the ai world summit can add value—by convening product builders, healthcare leaders, and policymakers to shape best practices before the category becomes fragmented or driven only by vendor claims.